Discover the European project DERMA during MedFIT on June 25th during a roundtable exchange:

– Scientific and Technical context – Dr. Iain Allan, Principal Research Fellow, University of Brighton
– Road to market and opportunity of tech transfer – Charles Sanson, Innovation Manager and Tech Transfer Officer, Eurasanté

DERMA, an Interreg 2 Seas project, aims to develop new interventions for the management and treatment of dermal ulcers and related skin conditions, including stomas. By addressing market and patient need, the project will deliver advanced new technologies ready for exploitation by industry to manufacture improved products for the treatment of patients.

Challenge: By 2025 more than 25% of Europeans will be 65 or older, a vulnerable group in relation to illness. This is a cross-border phenomenon that will challenge healthcare providers. Ulceration of the extremities of this group is a major societal challenge. Moreover the presence of diabetes, cardiovascular diseases, fungating tumours and long-term immobilization, exposes all age groups to dermal ulceration. To tackle effectively this growing issue, new improved technologies and management options to reduce costs and improve outcomes are needed.

Objectives: The main scientific objectives of DERMA are to design, develop and evaluate an odour-absorbing, antimicrobial wound dressing and a dressing with diagnostic capability to indicate wound status.